Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70

Oncology Reports

Volumn 30, Issue 3, 2013, Pages 1249-1256

  Gong, Wei ^a   Wang, Zhi Yong ^a   Chen, Guo Xi ^b   Liu, Yu Qiao ^a   Gu, Xiao Yan ^a   Liu, Wen Wei ^a  

^a HUBEI UNIVERSITY OF ARTS AND SCIENCE   (China)

^b Department of Respiratory Medicine   (China)

Author keywords

Heat shock protein 70; High mobility group protein B1; NF B; Toll like receptor 2 4; Tumor invasion

Indexed keywords

BECLIN 1; GELATINASE B; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FLOW CYTOMETRY; HMGB1 PROTEIN; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84880610121     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2595     Document Type: Article

References (29)

1. Sato Y, Goto Y, Narita N and Hoon DS: Cancer cells expressing Toll-like receptors and the tumor microenvironment. Cancer Microenviron 2: S205-S214, 2009.
2. Srikrishna G and Freeze HH: Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11: 615-628, 2009.
3. Huang B, Zhao J, Shen S, et al: Listeria monocytogenes promotes tumor growth via tumor cell toll like receptor 2 signaling. Cancer Res 67: 4346-4352, 2007.
4. Korbelik M, Zhang W and Merchant S: Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunol Immunother 60: 1431-1437, 2011.
5. Jäättelä M: Escaping cell death: survival proteins in cancer. Exp Cell Res 248: 30-43, 1999.
6. Basu S, Binder RJ, Suto R, Anderson KM and Srivastava PK: Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappaB pathway. Int Immunol 12: 1539-1546, 2000.
7. Bausero MA, Gastpar R, Multhoff G and Asea A: Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72. J Immunol 175: 2900-2912, 2005.
8. Li S, Zhou Y, Fan J, Cao S, et al: Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats. Am J Pathol 179: 2822-2834, 2011.
9. Pikarsky E, Porat RM, Stein I, Abramovitch R, et al: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466, 2004.
10. Ellerman JE, Brown CK, de Vera M, et al: Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13: 2836-2848, 2007.
11. Taguchi A, Blood DC, del Toro G, et al: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360, 2000.
12. Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342, 2005.
13. Tang D, Kang R, Cheh CW, et al: HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29: 5299-5310, 2010.
14. Tang D, Kang R, Zeh HJ III and Lotze MT: High-mobility group box 1 and cancer. Biochim Biophys Acta 1799: 131-140, 2010.
15. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, et al: Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13: 1050-1059, 2007.
16. Geng H, Zhang GM, Xiao H, et al: HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression ofpulmonary metastatic melanoma. Int J Cancer 118: 2657-2664, 2006.
17. Gong W, Zhang GM, Liu Y, et al: IFN-gamma withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin alphavbeta3 signaling. Int J Cancer 123: 702-708, 2008.
18. Tsan MF and Gao B: Endogenous ligands of Toll-like receptors. J Leukoc Biol 76: 514-519, 2004.
19. Asea A, Rehli M, Kabingu E, Boch JA, et al: Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277: 15028-15034, 2002.
20. Asea A: Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72. Curr Immunol Rev 2: 209-215, 2006.
21. Youn HS, Lee JY, Fitzgerald KA, et al: Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175: 3339-3346, 2005.
22. Mosser DD and Morimoto RI: Molecular chaperones and the stress of oncogenesis. Oncogene 23: 2907-2918, 2004.
23. Tang D, Loze MT, Zeh HJ and Kang R: the redox protein HMGB1 regulates cell death and survival in cancer treatment. Autophagy 6: 1181-1183, 2010.
24. Rohde M, Daugaard M, Jensen MH, et al: Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 19: 570-582, 2005.
25. Wu CX, Sun H, Liu Q, Guo H and Gong JP: LPS induces HMGB1 relocation and release by activating the NF-κB-CBP signal transduction pathway in the murine macrophage like cell line RAW264.7. J Surg Res 175: 88-100, 2012.
26. van Beijnum JR, Buurman WA and Griffioen AW: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11: 91-99, 2008.
27. Lee JK, Kim SY, Kim YS, Lee WH, et al: Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem Pharmacol 77: 1391-1400, 2009.
28. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, et al: Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113: 1641-1650, 2004.
29. Shvartsman SY, Hagan MP, Yacoub A, Dent P, et al: Autocrine loops with positive feedback enable context-dependent cell signaling. Am J Physiol Cell Physiol 282: C545-C559, 2002.